InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Update

InnoCare Pharma Limited (OTCMKTS:INCPF) saw a significant growth in short interest in June. As of June 15th, there was short interest totalling 3,096,000 shares, a growth of 7.9% from the May 31st total of 2,868,000 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ? days.

InnoCare Pharma Price Performance

InnoCare Pharma stock opened at $3.26 on Thursday. The firm has a fifty day simple moving average of $3.26 and a two-hundred day simple moving average of $3.26. InnoCare Pharma has a twelve month low of $3.26 and a twelve month high of $3.72.

About InnoCare Pharma

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.